Search

everythinglearnresearchcommunity

for

Search:↓

Both treatments for alopecia areata showed similar modest effectiveness.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

The summit aimed to speed up finding treatments for alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

PRC1 is essential for proper skin development and stem cell formation by controlling gene activity.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

BMP signaling is important for skin color, affecting melanin production, pigment spread, and cell movement.

The research found that a specific skin cell type not only triggers hair growth but also controls hair color, and that aging can lead to hair loss and color changes.

Researchers found that the Leptin receptor is a consistent marker for hair follicle dermal cells, which may help future hair research.

Fgf20 is important for the development and regulation of the cells that form the base of hair follicles.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

BMP signaling controls hair growth and skin color.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Topical drugs and near-infrared light therapy show potential for treating alopecia.